WO2001023341A1 - Processes for the preparation of chemical compounds - Google Patents

Processes for the preparation of chemical compounds Download PDF

Info

Publication number
WO2001023341A1
WO2001023341A1 PCT/GB2000/003701 GB0003701W WO0123341A1 WO 2001023341 A1 WO2001023341 A1 WO 2001023341A1 GB 0003701 W GB0003701 W GB 0003701W WO 0123341 A1 WO0123341 A1 WO 0123341A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
process according
compound
water
solution
Prior art date
Application number
PCT/GB2000/003701
Other languages
French (fr)
Inventor
Adrian Heseltine
Wei Tian
Julian Michael Cooper
Original Assignee
British Sugar Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Sugar Plc filed Critical British Sugar Plc
Priority to AU75348/00A priority Critical patent/AU7534800A/en
Publication of WO2001023341A1 publication Critical patent/WO2001023341A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C67/327Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by elimination of functional groups containing oxygen only in singly bound form
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to processes for the preparation of certain organic salts that are useful inter alia as sweetness inhibitors.
  • the present invention relates to processes for the preparation of the soluble salts of 4- methoxybenzoyloxyacetic acid and related compounds.
  • Sweetness inhibitors are food ingredients that counteract the perceived sweetness of sugars or other sweeteners in foodstuffs.
  • the addition of sweetness inhibitors enables sugars to be used in a wide variety of foods to perform functions other than sweetening, such as to act as fillers, bulking agents, antimicrobial agents, freezing point depressants and the like, without giving rise to unacceptable sweetness.
  • One such sweetness inhibitor is 2-(4-methoxyphenoxy)propanoic acid, which is commercially available under the Registered Trade Marks LACTISOLE and CYPHA from the Tate and Lyle Company.
  • GB-A-2180534 describes the use of 4-methoxybenzoyloxyacetic acid (hereinafter 4-MBA) and related compounds as sweetness inhibitors.
  • the 4-MBA is effective as a sweetness inhibitor when added at a level of about 0.5 to 2% by weight based on the weight of sugars in the foodstuff.
  • GB-A-2180534 also describes a method of synthesis of 4-MBA. The method comprises reacting 4- methoxybenzoic acid (anisic acid) with benzyl-2-bromoacetate in presence of potassium carbonate in refluxing acetone to produce benzyl (p- methoxybenzoyloxy)acetate.
  • the present inventors have found that adding alkali, such as sodium hydroxide, to precipitate the sodium salt of 4-MBA from a solution of 4-MBA in absolute ethanol solution results in an unsatisfactory product.
  • the neutralisation reaction is slow, and it is difficult to control the pH during the neutralisation and achieve a clear end-point in the ethanolic solution.
  • the sodium salt of 4-MBA precipitates as a microcrystalline or gelatinous mass that has poor mobility and filtration properties, and that has unsatisfactory purity.
  • the present invention provides a process for the preparation of a water-soluble salt of formula (I)
  • R 4 is OH or a carboxylate protecting group and the solvent for said solution comprises one or more C 1 to C ⁇ alcohols; and treating said solution with an alkali salt of X n+ in the presence of at least 0.5% w/v of water to precipitate said compound of formula (I) from said alcoholic solution.
  • R1 is alkoxy, and more preferably R 1 is methoxy.
  • at least three of R 2 are H, and more preferably all of R 2 are H.
  • at least one of R 3 is H, and more preferably both of R 3 are H.
  • the cation X n+ is selected from the group consisting of Na + , K + , NH 4 + , and mixtures thereof. More preferably, the cation X n+ consists essentially of Na + .
  • the compound of formula I is the sodium salt of 4-MBA.
  • the protecting group R 4 refers to any moiety that permits the compound of Formula II to react with alkali in alcoholic solution under mild conditions to form a carboxylate terminal group.
  • the group R 4 may for example link to the molecule of formula II as part of an ester group, an amide group or an anhydride group.
  • the group R 4 is OH or a group OR 5 that links to form an ester linkage.
  • the group R 5 is preferably an alkyl group, an aryl group, or an aralkyl group, each group optionally being substituted. More preferably, R 4 is OH, C1 to C 6 alkoxy or phenyl C- ⁇ -C 6 alkyleneoxy. Most preferably, R 4 is OH.
  • the solvent for the alcoholic solution consists essentially of the one or more C1 to C ⁇ alcohols and water.
  • the one or more C 1 to C ⁇ alcohols are monohydnc alcohols. More preferably they comprise or consist essentially of methanol, ethanol, propanol or isopropanol, and most preferably the alcohol consists essentially of ethanol.
  • the precipitation step of the present invention is carried out in the presence of at least 0.5% w/v of water (based on the total volume of the reaction mixture).
  • the reaction mixture comprises from 0.5% to 20% w/v of water, more preferably from 1% to 8% w/v of water, still more preferably from 1.5% to 6% w/v of water, and most preferably from 2% to 5% w/v of water.
  • the water included in the alcoholic solvent for the neutralisation step is critical to ensure a suitable physical form. Its omission causes a thick, immobile precipitate of the salt to form instead of the fine, easily filtered crystalline precipitate.
  • the filter cake without water present during neutralisation has a dry substance content of 41%, whereas with the addition of water, the dry substance content increases to 78%.
  • the presence of water is critical to effective pH control during the neutralisation. It has been found that over-neutralisation causes extensive degradation of the final product and produces ethyl anisate as the main product. The better control over the precipitation step in the presence of water also improves the purity of the product, in particular by reducing solvent occlusion.
  • the present invention further provides a solid compound of formula I having a platelet crystalline morphology. That is to say, the crystals have two major dimensions and one minor dimension. Preferably, the dimensions are in the ratio 1 :0.2-1.0:0.01-0.1 , based on number averages.
  • the water may be present in the alcoholic solution in which the compound of formula II is dissolved.
  • the water is present in a solution of the alkali (the "base solution") that is added to the alcoholic solution of the compound of formula II to precipitate the salt of formula I.
  • the presence of the water in the base solution assists dissolution of the alkali in the base solution, gives a faster precipitation reaction with easier control over pH, and reduces the hydrolysis of the compound of formula II to p-anisic acid and hydroxyacetic acid.
  • the base solution comprises at least 2% w/v of water based on the volume of the base solution, more preferably at least 5% w/v of water, and most preferably at least 8% w/v of water.
  • the compound of formula (II) is produced by reaction between 4- methoxybenzoic acid and a compound of formula BrCH 2 COR 6 , wherein the group Re is a protecting group the same as R ⁇ as hereinbefore defined, except that the definition of R & does not include OH.
  • the reaction is carried out in the presence of a base and a suitable solvent under appropriate conditions.
  • Preferred conditions include K 2 CO 3 in refluxing acetone, or Cs 2 CO 3 in dimethylformamide at room temperature. Reactions of this type are described in detail in GB-A-2180534 and by Tzougraki and Meinhofer in J. Org. Chem., 1977, vol.42, pp. 1286-1290, and also by A.G. Katopodis and S.W. May in Biochem., 1990, vol.29, pp.4541-4548.
  • removal of a protecting alkoxy group R 6 can be achieved simply by alkali hydrolysis, for example using KOH in ethanol/water (4:1 ) at room temperature to yield a solution of the potassium salt in ethanol/water, followed by work-up to yield the free carboxylic acid, as described by D.J. Ringshaw and H.J. Smith in J. Chem. Soc, 1964, pp. 1559-1562.
  • the expected yield for this route is rather low because of competing hydrolysis and transesterification reactions.
  • the concentration of the compound of formula II in the alcoholic solution is preferably in the range 0.05 to 0.6 g/ml, more preferably 0.1 to 0.4 g/ml. It has been found that higher concentrations result in esterification or transesterification of the compound of formula II with the alcoholic solvent to form the corresponding ester. For the same reason, the alcoholic solutions are preferably processed quickly and not allowed to stand for more than 48 hours, preferably not more than 6 hours and most preferably not more than 1 hour.
  • the neutralisation step of the process according to the present invention is preferably carried out at a temperature of 0 to 100 °C, more preferably 10 to 50 °C and most preferably 15 to 35 ° C.
  • the alkali is added over a period of 5 to 100 minutes, preferably 10 to 60 minutes, and most preferably 15 to 30 minutes.
  • the solution is neutralised to pH 4.5 to 8.5, more preferably to pH 6.0 to 8.5.
  • the pH of the reaction mixture is not allowed to exceed 8.5 in order to minimise hydrolysis and transesterification of the product.
  • the precipitated salt of formula I is separated from the reaction mixture by filtration.
  • the filtered solid is washed with cold, pure alcohol and dried.
  • the salt is then combined with a particulate sugar such as granulated sucrose at a level of 0.05 to 2.0 % w/w based on the weight of the sugar to provide a sugar having reduced sweetness.
  • the step of combining may, for example, be performed by physical dry mixing of particles, or by coating an aqueous solution of the salt onto particles of the sugar, for example by spray coating.
  • a salt of formula I can be co-crystallised with sugar from the aqueous solution of sugar and salt of formula I.
  • the present invention provides a reduced sweetness sugar product consisting essentially of sugar particles coated with a salt of formula I.
  • the sugar is granulated sucrose.
  • the compound of formula I is present in an amount of 0.5 to 2.0 % w/w based on the weight of the product.
  • the sodium salt of 4-MBA was prepared as follows. In a first stage, 4- methoxybenzoic acid (p-anisic acid) was reacted with benzyl-2-bromoacetate by reflux in acetone in the presence of a 100% molar excess of potassium carbonate. The potassium carbonate served as an acid scavenger for hydrogen bromide as it was formed. The benzyl function served as a protecting group to prevent dimerisation or oligomerisation of the bromoacetate moiety. The reaction time was about 18 hours. After reaction, the batch was filtered to remove the inorganic salts, the acetone is then distilled off, and the resulting slurry of the product was filtered and washed with 100% ethanol. An overall yield of about 90% was achieved.
  • the next stage in the process was the removal of the protective benzyl group by selective cleavage of the respective ester function using hydrogen and a palladium on charcoal catalyst. Once the reaction was complete, the catalyst was removed by filtration. No further work-up was carried out prior to the final stage.
  • the typical procedure uses 200 g of the 4-methoxybenzoyloxy acetic acid benzyl ester from the first stage, 800 mis of absolute ethanol solvent, 2.0 g of 10% palladium on activated charcoal, and hydrogen pressurised to 50 psi at 20-25°C.
  • the reaction was very rapid. It was preferred to use relatively dilute ethanol solutions and to process the solutions promptly, in order to minimise derivatisation to the corresponding ethyl ester by reaction with the ethanol solvent. (The water content of the 100% ethanol used throughout this work was determined by Karl Fischer titration at 0.18% w/w).
  • the process involved neutralisation of the 4-MBA free acid in absolute ethanol with sodium hydroxide to give the sodium salt of 4-MBA.
  • the sodium hydroxide was added as a solution in ethanol (the "base solution") containing a little water.
  • the reaction was monitored using pH measurement.
  • the precipitate was isolated by filtration.
  • a 5% molar excess of sodium hydroxide was used, and the base solvent for the sodium hydroxide contained 8% w/v of water. It was found that the sodium hydroxide readily dissolved in the base solution containing 8% w/v of water.
  • the concentration of the sodium hydroxide in the base solution was approximately 2.8 molar.
  • the concentration of the 4-MBA free acid in the ethanolic solution before addition of the base solution was approximately 0.8 molar.
  • the base solution was added at 20-25° to the ethanolic solution from stage 2 while monitoring the pH continuously with an electrode. Over-neutralisation must be avoided since this results in cleavage of the benzoyl ester. Therefore, neutralisation was stopped when the pH reached 8.5 ⁇ 0.3. The total duration of the neutralisation was about 30 minutes.
  • the reaction mixture containing the precipitated salt was cooled below 10°C and filtered under vacuum and washed with ethanol chilled below 10°C. The resulting white powder from the vacuum filter and drier was dried at 40-45°C. The yield is nearly quantitative.
  • the product had a purity of over 99% as determined by HPLC. Titration showed that the product contained no more than 3% of non-neutralised 4-MBA (HPLC cannot distinguish between the acid and salt forms of 4-MBA). Other impurities were ethanol (max 1%), acetone (max 100ppm) and toluene (max 5 ppm).
  • the product comprised mainly platelet-like crystals of typical dimensions 100x50x5 micrometers.
  • the above neutralisation step was repeated with a 4.8% w/w in the base solution and with 2.4% w/w water in the base solution. It was found that reducing the amount of water in the base solution meant that it took longer to dissolve the sodium hydroxide in the solution. However, at all water contents, it was found that the presence of water maintains the mobility of the 4-MBA sodium salt precipitate, speeds up filtration, improves pH control, and gives a more free-flowing product.
  • the above neutralisation step was carried out in the absence of any added water in the ethanolic or base solutions. It was found that the sodium hydroxide took a longer time to dissolve in the base solution. When the base solution was added over 50 minutes to the ethanolic solution, significant thickening occurred when a buffering point of pH 7.5 was reached. Adjusting to pH was extremely difficult, and the precipitate had a very fine consistency. The overall yield on filtration was only 94.4%.

Abstract

The invention provides a process for the preparation of a water-soluble salt of formula (I) wherein: R1 is hydroxy or C1-C4 alkoxy, or R1 and an adjacent R2 together form a methylenedioxy ring; each R2 is independently H, C1-C3 alkyl, C1-C2 alkoxy, OH or carboxymethoxy provided that at least two R2 groups are H; R3 is H or methyl; and Xn+ is a food-acceptable cation wherein n=1,2,3 or 4, said process comprising the steps of: providing an alcoholic solution of a compound of formula (II) wherein R¿4? is OH or a carboxylate protecting group and the solvent for said solution comprises one or more C1 to C6 alcohols; and treating said solution with an alkali salt of X?n+¿ in the presence of at least 0.5 % w/v of water to precipitate said compound of formula (I) from said alcoholic solution. The presence of a small amount of water in the reaction mixture results in a more tractable product of higher yield and purity.

Description

PROCESSES FOR THE PREPARATION OF CHEMICAL COMPOUNDS
The present invention relates to processes for the preparation of certain organic salts that are useful inter alia as sweetness inhibitors. In particular, the present invention relates to processes for the preparation of the soluble salts of 4- methoxybenzoyloxyacetic acid and related compounds.
Sweetness inhibitors are food ingredients that counteract the perceived sweetness of sugars or other sweeteners in foodstuffs. The addition of sweetness inhibitors enables sugars to be used in a wide variety of foods to perform functions other than sweetening, such as to act as fillers, bulking agents, antimicrobial agents, freezing point depressants and the like, without giving rise to unacceptable sweetness. One such sweetness inhibitor is 2-(4-methoxyphenoxy)propanoic acid, which is commercially available under the Registered Trade Marks LACTISOLE and CYPHA from the Tate and Lyle Company.
GB-A-2180534 describes the use of 4-methoxybenzoyloxyacetic acid (hereinafter 4-MBA) and related compounds as sweetness inhibitors. The 4-MBA is effective as a sweetness inhibitor when added at a level of about 0.5 to 2% by weight based on the weight of sugars in the foodstuff. GB-A-2180534 also describes a method of synthesis of 4-MBA. The method comprises reacting 4- methoxybenzoic acid (anisic acid) with benzyl-2-bromoacetate in presence of potassium carbonate in refluxing acetone to produce benzyl (p- methoxybenzoyloxy)acetate. Removal of the protecting benzyl group from the benzyl (p-methoxybenzoyloxyacetate) was accomplished by catalytic hydrogenation using 10% palladium on carbon in 100% ethanol. The product was filtered to remove the catalyst, and the ethanol was removed to obtain 4-MBA as a white crystalline solid. The reference mentions the possibility of using salts of 4- MBA as sweetness inhibitors, but no example is given of the preparation or use of such salts, and 4-MBA and its salts have not hitherto been commercially available for sweetness inhibition. 4-MBA itself is only sparingly soluble in water, which can make it difficult to formulate with crystalline sugars to prepare a low-sweetness particulate, soluble sugar product for use in the food industry. However, certain salts of 4-MBA, such as the sodium, potassium and ammonium salts thereof, are very soluble in water. A need therefore exists for a method of synthesis of such soluble salts of 4-MBA.
The present inventors have found that adding alkali, such as sodium hydroxide, to precipitate the sodium salt of 4-MBA from a solution of 4-MBA in absolute ethanol solution results in an unsatisfactory product. The neutralisation reaction is slow, and it is difficult to control the pH during the neutralisation and achieve a clear end-point in the ethanolic solution. Furthermore, the sodium salt of 4-MBA precipitates as a microcrystalline or gelatinous mass that has poor mobility and filtration properties, and that has unsatisfactory purity.
The present inventors have surprisingly found that the above-identified disadvantages can be overcome without significant reduction in yield by including a small amount of water in the ethanol solvent for the neutralisation step
Accordingly, the present invention provides a process for the preparation of a water-soluble salt of formula (I)
Figure imgf000003_0001
wherein: Ri is hydroxy or C1-C4 alkoxy, or R-i and an adjacent R2 together form a methylenedioxy ring; each R2 is independently H, C C3 alkyl, C C2 alkoxy, OH or carboxymethoxy provided that at least two R2 groups are H; R3 is H or methyl; and Xn+ is a food-acceptable cation wherein n=1 ,2,3 or 4, said process comprising the steps of: providing an alcoholic solution of a compound of formula (II)
Figure imgf000004_0001
wherein R4 is OH or a carboxylate protecting group and the solvent for said solution comprises one or more C1 to C§ alcohols; and treating said solution with an alkali salt of Xn+ in the presence of at least 0.5% w/v of water to precipitate said compound of formula (I) from said alcoholic solution.
Preferably, R1 is alkoxy, and more preferably R1 is methoxy. Preferably at least three of R2 are H, and more preferably all of R2 are H. Preferably at least one of R3 is H, and more preferably both of R3 are H. Preferably, the cation Xn+ is selected from the group consisting of Na+, K+, NH4 +, and mixtures thereof. More preferably, the cation Xn+ consists essentially of Na+. Most preferably, the compound of formula I is the sodium salt of 4-MBA.
The protecting group R4 refers to any moiety that permits the compound of Formula II to react with alkali in alcoholic solution under mild conditions to form a carboxylate terminal group. The group R4 may for example link to the molecule of formula II as part of an ester group, an amide group or an anhydride group. Preferably, the group R4 is OH or a group OR5 that links to form an ester linkage. The group R5 is preferably an alkyl group, an aryl group, or an aralkyl group, each group optionally being substituted. More preferably, R4 is OH, C1 to C6 alkoxy or phenyl C-ι-C6 alkyleneoxy. Most preferably, R4 is OH.
Preferably, the solvent for the alcoholic solution consists essentially of the one or more C1 to Cβ alcohols and water. Preferably, the one or more C1 to Cε alcohols are monohydnc alcohols. More preferably they comprise or consist essentially of methanol, ethanol, propanol or isopropanol, and most preferably the alcohol consists essentially of ethanol.
The precipitation step of the present invention is carried out in the presence of at least 0.5% w/v of water (based on the total volume of the reaction mixture). Preferably, high levels of water content are avoided in order to minimise the solubility of the salt in the aqueous alcoholic solvent. Preferably, the reaction mixture comprises from 0.5% to 20% w/v of water, more preferably from 1% to 8% w/v of water, still more preferably from 1.5% to 6% w/v of water, and most preferably from 2% to 5% w/v of water.
The water included in the alcoholic solvent for the neutralisation step is critical to ensure a suitable physical form. Its omission causes a thick, immobile precipitate of the salt to form instead of the fine, easily filtered crystalline precipitate. Typically, the filter cake without water present during neutralisation has a dry substance content of 41%, whereas with the addition of water, the dry substance content increases to 78%. Furthermore, the presence of water is critical to effective pH control during the neutralisation. It has been found that over-neutralisation causes extensive degradation of the final product and produces ethyl anisate as the main product. The better control over the precipitation step in the presence of water also improves the purity of the product, in particular by reducing solvent occlusion.
Finally, it has been found that there is distinct difference in crystal morphology between the product neutralised with and without the presence of water. Typically, in the absence of water, the crystals appear to be needle shaped with a dimension of 100x10x5 micrometers. In contrast, the crystals formed in the presence of water appear to be flake-like with typical dimensions of 100x50x5 micrometers. These flake-like crystalline structures are less likely to form dense aggregates and are therefore more free flowing and should be easier to disperse in water. This will offer advantages in terms of a more uniform distribution of 4- MBA salts when blending with carriers such as sugar or other sweeteners. Accordingly, the present invention further provides a solid compound of formula I having a platelet crystalline morphology. That is to say, the crystals have two major dimensions and one minor dimension. Preferably, the dimensions are in the ratio 1 :0.2-1.0:0.01-0.1 , based on number averages.
The water may be present in the alcoholic solution in which the compound of formula II is dissolved. However, preferably the water is present in a solution of the alkali (the "base solution") that is added to the alcoholic solution of the compound of formula II to precipitate the salt of formula I. The presence of the water in the base solution assists dissolution of the alkali in the base solution, gives a faster precipitation reaction with easier control over pH, and reduces the hydrolysis of the compound of formula II to p-anisic acid and hydroxyacetic acid. Preferably, the base solution comprises at least 2% w/v of water based on the volume of the base solution, more preferably at least 5% w/v of water, and most preferably at least 8% w/v of water.
A number of routes are available to the compound of formula (II). Preferably, the compound of formula (II) is produced by reaction between 4- methoxybenzoic acid and a compound of formula BrCH2COR6, wherein the group Re is a protecting group the same as R< as hereinbefore defined, except that the definition of R& does not include OH. The reaction is carried out in the presence of a base and a suitable solvent under appropriate conditions. Preferred conditions include K2CO3 in refluxing acetone, or Cs2CO3 in dimethylformamide at room temperature. Reactions of this type are described in detail in GB-A-2180534 and by Tzougraki and Meinhofer in J. Org. Chem., 1977, vol.42, pp. 1286-1290, and also by A.G. Katopodis and S.W. May in Biochem., 1990, vol.29, pp.4541-4548.
In cases where a compound of formula (II) in which R4 = OH is desired, it is necessary to carry out a further step to remove the protecting group Re and replace it by OH. This further step is preferably achieved by catalytic hydrogenation preferably at temperatures of 0 to 100 °C using a palladium catalyst such as 10% palladium on carbon, hydrogen preferably at 0.1 to 1.0 MPa, and a solvent which is preferably absolute ethanol or methanol. Reactions of this type are described in the above-referenced publications.
Alternatively, removal of a protecting alkoxy group R6 can be achieved simply by alkali hydrolysis, for example using KOH in ethanol/water (4:1 ) at room temperature to yield a solution of the potassium salt in ethanol/water, followed by work-up to yield the free carboxylic acid, as described by D.J. Ringshaw and H.J. Smith in J. Chem. Soc, 1964, pp. 1559-1562. However, the expected yield for this route is rather low because of competing hydrolysis and transesterification reactions.
Further routes to compounds of formula (II) in which R = OH are described in the following references: H.G. Thomas and S. Kessel in Chem. Ber., 1985, vol. 118, pp. 2777-2788; N.M. Nielsen and H. Bundegaard in J. Pharm. Sci., 1988, vol. 77, pp. 285-298; J.E. Shaw, D.C. Kunerth and J.J. Sherry in Tet. Lett., 1973, vol. 9, pp. 689-692; J.E. Shaw and D.C. Kunerth in J. Org. Chem., 1974, vol. 39, pp. 1968-1970; and Y-H. Kuo and C-J. Shieh in Heterocycles, 1986, vol. 24, pp. 1271-1274.
The concentration of the compound of formula II in the alcoholic solution is preferably in the range 0.05 to 0.6 g/ml, more preferably 0.1 to 0.4 g/ml. It has been found that higher concentrations result in esterification or transesterification of the compound of formula II with the alcoholic solvent to form the corresponding ester. For the same reason, the alcoholic solutions are preferably processed quickly and not allowed to stand for more than 48 hours, preferably not more than 6 hours and most preferably not more than 1 hour.
The neutralisation step of the process according to the present invention is preferably carried out at a temperature of 0 to 100 °C, more preferably 10 to 50 °C and most preferably 15 to 35 °C. Preferably the alkali is added over a period of 5 to 100 minutes, preferably 10 to 60 minutes, and most preferably 15 to 30 minutes.
Preferably, the solution is neutralised to pH 4.5 to 8.5, more preferably to pH 6.0 to 8.5. Preferably the pH of the reaction mixture is not allowed to exceed 8.5 in order to minimise hydrolysis and transesterification of the product.
Preferably, the precipitated salt of formula I is separated from the reaction mixture by filtration. Preferably, the filtered solid is washed with cold, pure alcohol and dried. In certain preferred embodiments of the present invention, the salt is then combined with a particulate sugar such as granulated sucrose at a level of 0.05 to 2.0 % w/w based on the weight of the sugar to provide a sugar having reduced sweetness. The step of combining may, for example, be performed by physical dry mixing of particles, or by coating an aqueous solution of the salt onto particles of the sugar, for example by spray coating. Alternatively, a salt of formula I can be co-crystallised with sugar from the aqueous solution of sugar and salt of formula I.
Accordingly, the present invention provides a reduced sweetness sugar product consisting essentially of sugar particles coated with a salt of formula I. Preferably, the sugar is granulated sucrose. Preferably, the compound of formula I is present in an amount of 0.5 to 2.0 % w/w based on the weight of the product.
Specific embodiments of the present invention will now be described further with reference to the following examples.
Example 1
The sodium salt of 4-MBA was prepared as follows. In a first stage, 4- methoxybenzoic acid (p-anisic acid) was reacted with benzyl-2-bromoacetate by reflux in acetone in the presence of a 100% molar excess of potassium carbonate. The potassium carbonate served as an acid scavenger for hydrogen bromide as it was formed. The benzyl function served as a protecting group to prevent dimerisation or oligomerisation of the bromoacetate moiety. The reaction time was about 18 hours. After reaction, the batch was filtered to remove the inorganic salts, the acetone is then distilled off, and the resulting slurry of the product was filtered and washed with 100% ethanol. An overall yield of about 90% was achieved.
The next stage in the process was the removal of the protective benzyl group by selective cleavage of the respective ester function using hydrogen and a palladium on charcoal catalyst. Once the reaction was complete, the catalyst was removed by filtration. No further work-up was carried out prior to the final stage. The typical procedure uses 200 g of the 4-methoxybenzoyloxy acetic acid benzyl ester from the first stage, 800 mis of absolute ethanol solvent, 2.0 g of 10% palladium on activated charcoal, and hydrogen pressurised to 50 psi at 20-25°C. The reaction was very rapid. It was preferred to use relatively dilute ethanol solutions and to process the solutions promptly, in order to minimise derivatisation to the corresponding ethyl ester by reaction with the ethanol solvent. (The water content of the 100% ethanol used throughout this work was determined by Karl Fischer titration at 0.18% w/w).
In the final stage, the process involved neutralisation of the 4-MBA free acid in absolute ethanol with sodium hydroxide to give the sodium salt of 4-MBA. The sodium hydroxide was added as a solution in ethanol (the "base solution") containing a little water. The reaction was monitored using pH measurement. The precipitate was isolated by filtration. A 5% molar excess of sodium hydroxide was used, and the base solvent for the sodium hydroxide contained 8% w/v of water. It was found that the sodium hydroxide readily dissolved in the base solution containing 8% w/v of water. The concentration of the sodium hydroxide in the base solution was approximately 2.8 molar. The concentration of the 4-MBA free acid in the ethanolic solution before addition of the base solution was approximately 0.8 molar.
The base solution was added at 20-25° to the ethanolic solution from stage 2 while monitoring the pH continuously with an electrode. Over-neutralisation must be avoided since this results in cleavage of the benzoyl ester. Therefore, neutralisation was stopped when the pH reached 8.5 ± 0.3. The total duration of the neutralisation was about 30 minutes. When the pH was steady in this range, the reaction mixture containing the precipitated salt was cooled below 10°C and filtered under vacuum and washed with ethanol chilled below 10°C. The resulting white powder from the vacuum filter and drier was dried at 40-45°C. The yield is nearly quantitative.
The product had a purity of over 99% as determined by HPLC. Titration showed that the product contained no more than 3% of non-neutralised 4-MBA (HPLC cannot distinguish between the acid and salt forms of 4-MBA). Other impurities were ethanol (max 1%), acetone (max 100ppm) and toluene (max 5 ppm). The product comprised mainly platelet-like crystals of typical dimensions 100x50x5 micrometers.
Example 2
The above neutralisation step was repeated with a 4.8% w/w in the base solution and with 2.4% w/w water in the base solution. It was found that reducing the amount of water in the base solution meant that it took longer to dissolve the sodium hydroxide in the solution. However, at all water contents, it was found that the presence of water maintains the mobility of the 4-MBA sodium salt precipitate, speeds up filtration, improves pH control, and gives a more free-flowing product.
Example 3 (comparative)
The above neutralisation step was carried out in the absence of any added water in the ethanolic or base solutions. It was found that the sodium hydroxide took a longer time to dissolve in the base solution. When the base solution was added over 50 minutes to the ethanolic solution, significant thickening occurred when a buffering point of pH 7.5 was reached. Adjusting to pH was extremely difficult, and the precipitate had a very fine consistency. The overall yield on filtration was only 94.4%.
When the base solution was added quickly, over 27 minutes, the resulting precipitate was an immobile mass. Filtration was slow, and gave a very fine almost waxy solid which appeared to retain a larger proportion of solvent. The yield of material was only 86.9%.
The above embodiments have been described by way of example only. Many other embodiments falling within the scope of the accompanying claims will be apparent to the skilled reader. In particular, it will be apparent to the skilled reader that the salts obtained by the processes of the present invention may have other uses in addition to their use as sweetness inhibitors.

Claims

A process for the preparation of a water-soluble salt of formula (I)
Figure imgf000012_0001
wherein: Ri is hydroxy or C1-C4 alkoxy, or R-i and an adjacent R2 together form a methylenedioxy ring; each R2 is independently H, C1-C3 alkyl, d-C2 alkoxy, OH or carboxymethoxy provided that at least two R2 groups are H; R3 is H or methyl; and Xn+ is a food-acceptable cation wherein n=1 ,2,3 or 4,, said process comprising the steps of: providing an alcoholic solution of a compound of formula (II)
Figure imgf000012_0002
wherein R4 is OH or a carboxylate protecting group and the solvent for said solution comprises one or more C1 to Cβ alcohols; and treating said solution with an alkali salt of Xn+ in the presence of at least 0.5% w/v of water to precipitate said compound of formula (I) from said alcoholic solution.
2. A process according to claim 1 , wherein Ri is C1 to C4 alkoxy.
3. A process according to claim 1 or 2, wherein all of R2 are H.
4. A process according to claim 1 , 2 or 3, wherein R^ is methoxy, all of R2 are H, and all of R3 are H.
5. A process according to any preceding claim , wherein Xn+ comprises Na\ K+ or NH4 +.
6. A process according to claim 5, wherein Xn+ consists essentially of Na+.
7. A process according to any preceding claim, wherein R4 is OH, optionally substituted C-i to C6 alkoxy, or optionally substituted phenyl Ci to Cβ alkyleneoxy.
8. A process according to claim 7, wherein R4 is OH.
9. A process according to any preceding claim, wherein the solvent for said alcoholic solution consists essentially of said one or more Ci to C& alcohols and water.
10. A process according to any preceding claim, wherein said one or more Ci to C6 alcohols consist essentially of ethanol, methanol, isopropanol, propanol or mixtures thereof.
11. A process according to any preceding claim, wherein the concentration of the compound of formula II in the alcoholic solution is in the range 0.05 to 0.6 g/ml.
12. A process according to claim 11 , wherein the concentration of the compound of formula II in the alcoholic solution is in the range 0.1 to 0.4 g/ml.
13. A process according to any preceding claim, wherein said water is present in an amount of 0.5% to 20% w/v, based on the volume of the reaction mixture.
14. A process according to claim 13, wherein said water is present in an amount of 1.0% to 5% w/v, based on the volume of the reaction mixture.
15. A process according to any preceding claim, wherein said alkali is dissolved in an alcoholic solvent to provide a base solution that is then added to the alcoholic solution of compound of formula II.
16. A process according to claim 15, wherein said base solution comprises from 2% to 20% w/v of water.
17. A process according to claim 16, wherein said base solution comprises from 4% to 10% w/v of water.
18. A process according to any preceding claim, wherein said alkali is selected from the group consisting of hydroxides, carbonates and hydrogen carbonates of Xπ+ and mixtures thereof.
19. A process according to any preceding claim, wherein said step of providing an alcoholic solution of the compound of formula II comprises reacting 4- methoxybenzoic acid with a compound of formula BrCH2COR, provided that R is not OH, in the presence of a base, to form a compound of formula II.
20. A process according to claim 19, further comprising the step of reacting the compound of formula II with hydrogen over a catalyst to cleave the protecting group R and provide a compound of formula II in which R is OH.
21. A process according to any preceding claim, wherein R is OH and said alkali is added with monitoring of pH until a final pH of from 4.5 to 8.5 is reached.
22. A process according to any preceding claim, further comprising the step of providing the compound of formula I dispersed in or on a particulate sugar substrate by co-crystallising the compound of formula I with a sugar, or by dispersing a compound of formula I on a particulate sugar substrate, or by dry mixing.
23. A solid compound of formula I having a platelet crystalline morphology.
24. A reduced sweetness sugar product consisting essentially of particulate sugar having a compound of formula I dispersed thereon.
25. A reduced sweetness sugar product according to claim 24, wherein the particulate sugar is granulated sucrose.
PCT/GB2000/003701 1999-09-28 2000-09-27 Processes for the preparation of chemical compounds WO2001023341A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU75348/00A AU7534800A (en) 1999-09-28 2000-09-27 Processes for the preparation of chemical compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9922980A GB2354761A (en) 1999-09-28 1999-09-28 Preparation of benzoyloxy acetic acid derivatives
GB9922980.9 1999-09-28

Publications (1)

Publication Number Publication Date
WO2001023341A1 true WO2001023341A1 (en) 2001-04-05

Family

ID=10861776

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/003701 WO2001023341A1 (en) 1999-09-28 2000-09-27 Processes for the preparation of chemical compounds

Country Status (3)

Country Link
AU (1) AU7534800A (en)
GB (1) GB2354761A (en)
WO (1) WO2001023341A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9486463B2 (en) 2010-10-19 2016-11-08 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2180534A (en) * 1985-09-19 1987-04-01 Gen Foods Corp Benzoyloxyacetic acid derivatives useful as sweetness inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2180534A (en) * 1985-09-19 1987-04-01 Gen Foods Corp Benzoyloxyacetic acid derivatives useful as sweetness inhibitors

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US9486463B2 (en) 2010-10-19 2016-11-08 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies

Also Published As

Publication number Publication date
GB9922980D0 (en) 1999-12-01
AU7534800A (en) 2001-04-30
GB2354761A (en) 2001-04-04

Similar Documents

Publication Publication Date Title
EP0670825B1 (en) Nitric esters having a pharmacological activity and process for their preparation
US4447419A (en) Thiazole derivative, and pharmaceutical compositions containing it
SI9720039A (en) Process for the preparation of 1-alkoxycarbonyl-3-phenyl-propyl derivatives
US6291004B1 (en) Basic salts of n-[n-(3,3-dimethylbutyl)-l-α-aspartyl]-l-phenylalanine 1-methyl ester
EP0092933B1 (en) Process for producing alpha-l-aspartyl-l-phenylalanine methyl ester or its hydrochloride
EP0417256B1 (en) Novel n-(sulfomethyl)-n&#39;-arylureas
EP1012169A1 (en) SWEETENER SALTS OF N- N-(3,3-DIMETHYLBUTYL) -L-$g(a)-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO2001023341A1 (en) Processes for the preparation of chemical compounds
FI95195C (en) preservative Mixes
JPH0587239B2 (en)
EP0512435B1 (en) Method of crystallizing aspartame
EP0058063B1 (en) Process for removing an n-formyl group
US4673744A (en) Method for conversion of β-aspartylphenylalanine derivatives to .alpha.
US6649784B2 (en) Aspartyl dipeptide ester derivatives and sweeteners
KR930007432B1 (en) Process for preparing alpha-l-aspartyl-l-phenylalanin methyl ester
CH659061A5 (en) SYNTHESIS OF ASPARTAME.
KR880002623B1 (en) Selective acylation of hydroxyamino-arylsulfonic acids
KR20010080748A (en) Macrolide Intermediates in the Preparation of Clarithronmycin
US3492347A (en) Preparation of optically active alpha-methyl-phenylalanine derivatives
EP0446180A1 (en) 5-Phenyl-1H-pyrazol-4-propionic acid derivatives, their preparation and their use
KR890001852B1 (en) Process for the preparation of asparaginic acid peptide compounds
CZ293008B6 (en) Method for crystallizing maleic acid salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline
Nefkens et al. Synthesis of α‐esters of N‐acylaspartic acid
AU683956B2 (en) Novel process for preparing (S)-1-(2(S)-(1,3-dihydro-1,3-dioxo-isoindo-2-yl)-1-oxo-3- phenylpropyl)-1,2,3,4-tetrahydro-2-pyridine-carboxylic acid methyl ester and intermediates thereof
JPS6112919B2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP